loader2
Login Open ICICI 3-in-1 Account

GLENMARK LIFE SCIENCES FILES FOR IPO OF UP TO RS 1160 CR

Published on Apr 17, 2021 11:20

Glenmark Life Sciences, a wholly owned subsidiary of Glenmark Pharmaceuticals, has on 16 April 2021, filed a draft red herring prospectus with the Securities and Exchange Board of India for an initial public offer, comprising of a fresh issue of up to Rs 1160 crore and an offer for sale of up to 7,305,245 equity shares of Rs 2 each of Glenmark Life Sciences, by Glenmark Pharmaceuticals (Offer).

The board of directors of Glenmark Pharmaceuticals at its meeting held today, i.e. 16 April 2021, accorded its approval for the offer for sale of up to 7,305,245 equity shares of Rs 2, in the Offer.

Powered by Capital Market - Live News